WH: FDA Needs Additional Authority To Collect Drug Supply Chain Info

By Kelly Lienhard / June 8, 2021 at 7:24 PM

In a new supply chain report released Tuesday (June 8), the White House, HHS and FDA call for Congress to give FDA the power to collect information about drugs and drug ingredients moving through the U.S. supply chain, coming as the COVID-19 pandemic sheds light on several gaps in FDA’s ability to collect data on the availability of drug ingredients and respond to drug shortages.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.